Consumer Driven Health Care

Observers say that while capping the cost of insulin at $35 a month benefits consumers, it doesn't strengthen Lilly's legal arguments since the company and others raised list prices by 150% over five years, alleges one lawsuit.

Many surgical procedures proved to be pricier for hospitals in the network.

Facing pressure to curb diabetes treatment costs, the price cut puts the drugmaker's insulin in line with the Inflation Reduction Act, which last month capped the medication's cost for seniors on Medicare.

Fertility and adoption benefits have been rapidly increasing over the last seven years to attract and retain talent, to save on health care costs and to match diversity, equity and inclusion efforts, according to a new study.

Plan sponsors and employers could be providing guidance about making good Medicare plan choices to near- retirees, perhaps offering HSAs for supplemental retirement income, a new survey suggests.

We recently sat down with Brandon Weber, the co-founder and CEO at Nava Benefits, to get his thoughts on the state of the industry, the benefits trends he's watching, and the evolving role of the benefits advisor.